Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell

Molecular Medicine

Volumn 13, Issue 1-2, 2007, Pages 14-21

  Yao, Zhi ^a,b   Che, Xu Chun ^b   Lu, Rong ^b,c   Zheng, Min Na ^b   Zhu, Zhi Feng ^c   Li, Jin Ping ^c   Jian, Xu ^b   Shi, Lin Xi ^b   Liu, Jun Yan ^b   Gao, Wen Yuan ^a  

^a TIANJIN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c Shenzhen Kangzhe Pharmaceutical Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MATRIGEL; POLYPEPTIDE; TYROSERLEUTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER MODEL; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; INHIBITION KINETICS; LUNG METASTASIS; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL ADHESION; CELL PROLIFERATION; COLLAGEN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; FEMALE; LAMININ; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; PROTEOGLYCANS; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS; TUMOR CELLS, CULTURED;

EID: 34249028965     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00061.Yao     Document Type: Article

References (30)

1. Pan Y, Song QL, Lin YH, Lu N, Yu HM, Li XJ. (2005) GLB prevents tumor metastasis of Lewis lung carcinoma by inhibiting tumor adhesion actions. Acta Pharmacol. Sin. 26:881-6.
2. Muehlemann M, Miller KD, Dauphinee M, Mizejewski GJ. (2005) Review of growth inhibitory peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis. Cancer Metastasis Rev. 24:441-67.
3. Yamamoto Y, Tsutsumi Y, Mayumi T. (2002) Molecular design of bioconjugated cell adhesion peptide with a water-soluble polymeric modifier for enhancement of antimetastatic effect. Curr. Drug Targets 3:123-30.
4. Kato R et al. (2002) A new type of antimetastatic peptide derived from fibronectin. Clin. Cancer Res. 8:2455-62.
5. Lu R et al. (2005) Experimental study of the inhibition of human hepatocarcinoma Bel7402 cells by the tripeptide tyroserleutide (YSL). Cancer Chemother. Pharmacol. 57:1-9.
6. Kawasaki M, Maeda T, Hanasawa K, Ohkubo I, Tani T. (2003) Effect of His-Gly-Lys motif derived from domain 5 of high molecular weight kininogen on suppression of cancer metastasis both in vitro and in vivo. J. Biol. Chem. 278:49301-7.
7. Okegawa T, Pong RC, Li Y, Hsieh JT. (2004) The role of cell adhesion molecule in cancer progression and its application in cancer therapy Acta Biochim. Pol. 445-57.
8. Mummert ME, Mummert DI, Ellinger L, Takashima A. (2003) Functional roles of hyaluronan in B16-F10 melanoma growth and experimental metastasis in mice. Mol. Cancer Ther. 2:295-300.
9. McGary EC et al. (2003) A fully human anti-melanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. Clin. Cancer Res. 9:6560-6.
10. Sullivan RM, Stone M, Marshall JF, Uberall F, Rotenberg SA. (2000) Photo-induced inactivation of protein kinase calpha by dequalinium inhibits motility of murine melanoma cells. Mol. Pharmacol. 58:729-37.
11. Zhang XM, Huang SP, Xu Q. (2004) Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemother. Pharmacol. 53:82-8.
12. Dussault AA, Pouliot M. (2006) Rapid and simple comparison of messenger RNA levels using real-time PCR. Biol. Proc. Online 8:1-10.
13. Livak KJ, Schmittgen TD. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402-8.
14. Usui T, Ishida S, Yamashiro K, et al. (2004) VEGF164 (165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Vis. Sci. 45:368-74.
15. Yamaguchi H et al. (2003) Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem. J. 374:715-21.
16. Theiszova M, Jantova S, Dragunova J, Grznarova P, Palou M. (2005) Comparison the cytotoxicity of hydroxyapatite measured by direct cell counting and MTT test in murine fibroblast NIH-3T3 cells. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149:393-6.
17. Zheng HQ, Liu DY (2003) [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma]. Ai Zheng 22:363-7.
18. Ogasawara M, Matsunaga T, Takahashi S, Saiki I, Suzuki H. (2002) Anti-invasive and metastatic activities of evodiamine. Biol. Pharm. Bull. 25:1491-3.
19. Tachimori A et al. (2005) Up regulation of ICAM-1 gene expression inhibits tumor growth and liver metastasis in colorectal carcinoma. Eur. J. Cancer 41:1802-10.
20. Yashiro M, Sunami T, Hirakawa K. (2005) CD54 expression is predictive for lymphatic spread in human gastric carcinoma. Dig. Dis. Sci. 50:2224-30.
21. Lu H et al. (2005) Angiogenesis inhibitor Z24 induces endothelial cell apoptosis and suppresses rumor growth and metastasis. J. Pharmacol. Sci. 97:533-40.
22. Ren B, Hoti N, Rabasseda X, Wang YZ, Wu M. (2003) The antiangiogenic and therapeutic implications of endostatin. Methods Find Exp. Clin. Pharmacol. 25:215-24.
23. Liotta LA et al. (1988) Biochemical mechanisms of rumor invasion and metastases. Prog. Clin. Biol. Res. 256:3-16.
24. Wang Y et al. (2004) Inhibitors of 5-lipoxygenase inhibit expression of intercellular adhesion molecule-1 in human melanoma cells. Acta Pharmacol. Sin. 25:672-7.
25. Stratz T, Kees F, Muller W. (2003) Do cytochrome enzymes influence the therapeutic effect of tropisetron in fibromyalgia? Drugs Exp. Clin. Res. 29:91-4.
26. Patya M et al. (2004) Allicin stimulates lymphocytes and elicits an antitumor effect: a possible role of p21ras. Int. Immunol. 16:275-81.
27. Curnis F, Gasparri A, Sacchi A, Cattaneo A, Magni F, Corti A. (2005) Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms. Cancer Res. 65:2906-13.
28. Barnard R, Gurevich KG. (2005) In vitro bioassay as a predictor of in vivo response. Theor. Biol. Med. Model 2:3.
29. Paulsen JE. (1993) The synthetic colon peptide pyroGlu-His-GlyOH inhibits growth of human colon carcinoma cells (HT-29) transplanted subcutaneously into athymic mice. Carcinogenesis 14:1719-21.
30. Setyono-Han B, Henkelman MS, Foekens JA, Klijn GM. (1987) Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 47:1566-70.